Companies/Klaria Pharma Holding AB
Follow

Klaria Pharma Holding AB

Nasdaq First North GM Stockholm (Sweden)

Klaria Pharma is engaged in the development and commercialization of pharmaceutical products in Sweden for migraine and cancer-related pain. Its operations are based on a patented drug delivery platform in the form of an alginate-based polymer film.
Go to market

Sector:
HEALTH CARE
>
Drug Manufacturers - Specialty & Generic
Healthcare
Media
www.klaria.com
Current instruments
Type
Ticker
ISIN
SHARE
KLAR
SE0007280326
Nasdaq First North GM Stockholm Sweden (SE)
Top
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
KLAR
SE0007280326
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Klaria Pharma Holding AB with ticker KLAR
Status
Active
Currency
SEK
Listing
Sign in to buy
Directed issue
Sign in to buy
Directed issue
Sign in to buy
Directed issue
Sign in to buy
Non-cash issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
People
Jesper Wiklund
CEO
Fredrik Hübinette
Chairman of the board
Anders Ardstål
Board member
Scott Boyer
Board member
Company Details
Sector
HEALTH CARE
Website
Address
Virdings Allé 2
Zip code
754 50
City/district
Uppsala
Country
Sweden (SE)
Phones
Email
[email protected]
Registration number
556959-2917
LEI code
529900YLMSNHNP7HOD11
First trade date
21 Oct 2015
Registration date
22 Jan 2014
Short name
KLAR

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More